Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Abdominal Surgery
23%
Acid Peptic Disease
23%
Acid Suppression
25%
Acutely Ill Patients
23%
Antibiotics
53%
Bacterial Pneumonia
35%
Caco-2 Cells
26%
Caffeine
23%
Cefmetazole
23%
Cefoperazone
31%
Cefotetan
30%
Cefoxitin
30%
Cellulose Acetate
23%
Cephalosporins
20%
Cimetidine
60%
Clinical Practice
37%
Critically Ill Patients
22%
Dosage Regimen
24%
Drug Interactions
21%
Drug Therapy
26%
Famotidine
23%
Fasted State
20%
Formulary
23%
Gastric Acid
23%
Gastric Emptying
28%
Gastric Motility
23%
Generic Drugs
35%
Healthy Volunteers
22%
Histamine-2 Receptor Antagonists (H2RA)
27%
Hypoprothrombinemia
23%
Immediate Release
23%
Intensive Care Unit
26%
Omeprazole
23%
Pantoprazole
23%
Paroxetine
23%
Peptide Transporter 1 (PepT1)
31%
Pharmacist
23%
Pharmacokinetic Parameters
29%
Pharmacokinetics
85%
Pharmacology
31%
Pharmacotherapy
29%
Phenylalanine
22%
Propranolol
57%
Prospective Surveillance
21%
Proton Pump Inhibitors
90%
Ranitidine
31%
Theophylline
23%
Thermal Injury
35%
Vancomycin
23%
Verapamil
23%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
13%
Aminoglycoside
20%
Antibiotic Therapy
13%
Antibiotics
44%
Bacterial Pneumonia
35%
Burn
19%
Cefmetazole
23%
Cefoperazone
31%
Cefotetan
30%
Cefoxitin
32%
Cell Culture
13%
Cimetidine
60%
Congestive Heart Failure
14%
Cytokine
23%
Diseases
16%
Drug Absorption
30%
Drug Interaction
31%
Effusion
13%
Famotidine
23%
Homo sapiens
23%
Hypoprothrombinemia
24%
Intestinal Permeability
15%
Jejunum
14%
Jejunum Ulcer
32%
Kidney Failure
14%
Latamoxef
19%
Normal Human
57%
Omeprazole
23%
P-Glycoprotein
25%
Pantoprazole
23%
Paracetamol
23%
Paroxetine
23%
Peptic Ulcer
32%
Peptidomimetics
13%
Pharmacodynamics
19%
Pharmacokinetic Parameter
29%
Pharmacokinetics
100%
Pharmacotherapy
22%
Phenylalanine
21%
Polyethylene Glycol
19%
Propranolol
54%
Prothrombin
16%
Proton Pump
14%
Proton Pump Inhibitor
85%
Ranitidine
31%
Receptor Antagonist
24%
Sepsis
13%
Theophylline
23%
Thermal Injury
35%
Verapamil
23%